MANUFACTURERS LIFE INSURANCE COMPANY, THE - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$99,000
+106.2%
50,289
+30.9%
0.00%
Q4 2020$48,000
-11.1%
38,411
+28.3%
0.00%
Q3 2020$54,000
-82.4%
29,947
-22.9%
0.00%
Q2 2020$307,000
+45.5%
38,860
-3.5%
0.00%
Q1 2020$211,000
+8.2%
40,288
+12.8%
0.00%
Q4 2019$195,000
+4.3%
35,728
-4.4%
0.00%
Q3 2019$187,000
-27.8%
37,3890.0%0.00%
Q2 2019$259,000
+4.4%
37,389
+4.8%
0.00%
Q1 2019$248,000
+29.2%
35,681
+8.2%
0.00%
Q4 2018$192,000
-26.7%
32,964
-5.2%
0.00%
Q3 2018$262,000
+24.8%
34,762
-16.3%
0.00%
Q2 2018$210,000
-12.1%
41,537
+6.4%
0.00%
Q1 2018$239,000
-11.5%
39,053
+2.5%
0.00%
Q4 2017$270,000
+7.6%
38,103
+8.6%
0.00%
Q3 2017$251,000
+10.1%
35,086
-3.0%
0.00%
Q2 2017$228,000
+1241.2%
36,181
+1347.2%
0.00%
Q3 2016$17,0002,5000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders